Heterotrophic Skin Bacteria Composition for Treating UV Damage and PLE
Summary
The USPTO published patent application US20260097086A1 by inventor Catherine O'Neill for a composition comprising heterotrophic skin bacteria or bacterial extract for modulating cytokine expression in skin cells. The composition is intended for preventing and treating skin damage caused by UV light and for treating polymorphous light eruption (PLE).
What changed
The USPTO published patent application US20260097086A1 disclosing a composition comprising heterotrophic skin bacteria and/or heterotrophic skin bacterial extract for modulating cytokine expression in skin cells. The composition is claimed for use in preventing and treating skin damage caused by UV light and for treating polymorphous light eruption (PLE). The application was filed on September 20, 2023, and published on April 9, 2026.
This published application provides notice of the claimed invention to the public and establishes a priority date. Pharmaceutical and biotechnology companies developing microbiome-based skincare products, UV protection formulations, or dermatological treatments should review the claims for potential freedom-to-operate concerns. Competitors should monitor this application through grant to assess competitive implications.
What to do next
- Monitor for patent grant and issued claims
- Conduct freedom-to-operate analysis if developing similar compositions
- Assess potential licensing opportunities
Archived snapshot
Apr 9, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
COMPOSITIONS AND USES THEREOF
Application US20260097086A1 Kind: A1 Apr 09, 2026
Inventors
Catherine O'NEILL
Abstract
The present invention relates to a composition comprising a heterotrophic skin bacterium and/or heterotrophic skin bacterial extract for use in the modulation of cytokine expression in a skin cell. The composition is particularly suited for use in the prevention and/or treatment of skin damage caused by UV light and use in treating skin conditions such as polymorphous light eruption (PLE).
CPC Classifications
A61K 35/74 A61K 8/99 A61P 17/00 A61Q 19/004
Filing Date
2023-09-20
Application No.
19113160
Named provisions
Related changes
Get daily alerts for USPTO Patent Applications - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Applications - Therapeutics (A61P) publishes new changes.